1. Home
  2. OBAI vs IMNN Comparison

OBAI vs IMNN Comparison

Compare OBAI & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TG-17 Inc. Common Stock

OBAI

TG-17 Inc. Common Stock

HOLD

Current Price

$0.23

Market Cap

9.4M

ML Signal

HOLD

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$1.31

Market Cap

7.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBAI
IMNN
Founded
2017
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4M
7.9M
IPO Year
2025
2000

Fundamental Metrics

Financial Performance
Metric
OBAI
IMNN
Price
$0.23
$1.31
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $10.00
AVG Volume (30 Days)
★ 558.8K
129.3K
Earning Date
05-27-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 40.53
N/A
EPS
★ N/A
N/A
Revenue
★ $9,972,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 2.42
N/A
52 Week Low
$0.21
$1.29
52 Week High
$19.95
$5.55

Technical Indicators

Market Signals
Indicator
OBAI
IMNN
Relative Strength Index (RSI) 33.79 35.69
Support Level N/A N/A
Resistance Level $0.65 $1.59
Average True Range (ATR) 0.03 0.14
MACD -0.00 -0.00
Stochastic Oscillator 25.25 4.39

Price Performance

Historical Comparison
OBAI
IMNN

About OBAI TG-17 Inc. Common Stock

Our Bond Inc is a personal security service through its AI-powered Preventive Personal Security platform. It is trusted by corporations, cities, and universities, and has already supported many security service requests, emergencies and life-saving interventions. The cloud-based Bond Preventative Personal Security Platform provides users with remote protective services via phone app (using its Bond Preventative Personal Security Platform) and with 24/7 support from its Personal Security Agents, who are in Bond Command Centers and can respond rapidly. It offers distinct services through its phone app (the Bond App) and fully automated Bond Command Centers. Geographically, the company operates in Israel, France, and United States. It derives maximum revenue from United States.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

Share on Social Networks: